Andrx post-Wilma
Executive Summary
Davie, Fla.-based Andrx resumes manufacturing operations following Hurricane Wilma, the generic drug maker reports Oct. 26. The company says it suffered only minor damage to its facilities as a result of the storm. Andrx' distribution businesses, Anda and Valmed, with facilities in Florida, New York and Ohio, remained in continuous operation during the storm, Andrx says...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.